Sfoglia per Autore
Disease stabilization as a surrogate end point in advanced non small cell lung cancer patients treated with erlotinib or gefitinib
2007-01-01 Grossi, Francesco; Brianti, A; Defferrari, C; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Pronzato, P.
Gefitinib treatment outcome after progression on erlotinib in patients with advanced non-small-cell lung cancer (NSCLC)
2007-01-01 Defferrari, C; Brianti, A; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Pronzato, P; Grossi, Francesco
Skin toxicities difference between erlotinib and gefitinib in the treatment of advanced non-small-cell lung cancer (NSCLC)
2007-01-01 Brianti, A; Defferrari, C; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Grossi, Francesco; Pronzato, P.
Difference in skin toxicity incidence between erlotinib and gefitinib in the treatment of advanced non-small-cell lung cancer (NSCLC)
2008-01-01 Grossi, Francesco; Defferrari, C; Brianti, A; Dal Bello, Mg; Catania, Gianluca; Pronzato, P.
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients
2013-01-01 Puzone, R.; Savarino, G.; Salvi, S.; Dal Bello, M. G.; Barletta, G.; Genova, C.; Rijavec, E.; Sini, C.; Esposito, A. I.; Ratto, G. B.; Truini, M.; Grossi, F.; Pfeffer, U.
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system
2014-01-01 Truini, A.; Alama, A.; Dal-Bello, M. G.; Coco, S.; Vanni, I.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Grossi, F.
Looking for results in non-small-cell lung cancer: Is bio-chemotherapy the right answer?
2014-01-01 Genova, C.; Rijavec, E.; Grossi, F.
Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer
2014-01-01 Alama, A.; Truini, A.; Coco, S.; Genova, C.; Grossi, F.
Afatinib for the treatment of non-small cell lung cancer
2015-01-01 Biello, F.; Maggioni, C.; Rijavec, E.; Genova, C.; Barletta, G.; Gualco, E.; Truini, A.; Coco, S.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Boccardo, F.; Grossi, F.
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer
2016-01-01 Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F.
Hematopoietic growth factors in lung cancer
2016-01-01 Genova, C.; Rijavec, E.; Grossi, F.
Vinflunine for the treatment of non-small cell lung cancer
2016-01-01 Genova, C.; Alama, A.; Coco, S.; Rijavec, E.; Dal Bello, M. G.; Vanni, I.; Biello, F.; Barletta, G.; Rossi, G.; Grossi, F.
Recent advances in squamous non-small cell lung cancer: Evidence beyond predictive biomarkers
2016-01-01 Genova, C.; Rijavec, E.; Grossi, F.
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy
2016-01-01 Biello, Federica; Burrafato, Giovanni; Rijavec, Erika; Genova, Carlo; Barletta, Giulia; Truini, Anna; Coco, Simona; Bello, Maria Giovanna Dal; Alama, Angela; Boccardo, Francesco; Grossi, Francesco
Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: Can we use enemy territory at our advantage?
2017-01-01 Genova, C.; Rijavec, E.; Grossi, F.
Understanding the checkpoint blockade in lung cancer immunotherapy
2017-01-01 Dal Bello, M. G.; Alama, A.; Coco, S.; Vanni, I.; Grossi, F.
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study
2017-01-01 Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco
Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
2017-01-01 Grossi, F.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Maggioni, C.; Burrafato, G.; Sini, C.; Dal Bello, M. G.; Meyer, K.; Roder, J.; Roder, H.; Grigorieva, J.
Exosomes: a new horizon in lung cancer
2017-01-01 Vanni, I.; Alama, A.; Grossi, F.; Dal Bello, M. G.; Coco, S.
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy
2017-01-01 Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Disease stabilization as a surrogate end point in advanced non small cell lung cancer patients treated with erlotinib or gefitinib | 1-gen-2007 | Grossi, Francesco; Brianti, A; Defferrari, C; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Pronzato, P. | |
Gefitinib treatment outcome after progression on erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) | 1-gen-2007 | Defferrari, C; Brianti, A; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Pronzato, P; Grossi, Francesco | |
Skin toxicities difference between erlotinib and gefitinib in the treatment of advanced non-small-cell lung cancer (NSCLC) | 1-gen-2007 | Brianti, A; Defferrari, C; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Grossi, Francesco; Pronzato, P. | |
Difference in skin toxicity incidence between erlotinib and gefitinib in the treatment of advanced non-small-cell lung cancer (NSCLC) | 1-gen-2008 | Grossi, Francesco; Defferrari, C; Brianti, A; Dal Bello, Mg; Catania, Gianluca; Pronzato, P. | |
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients | 1-gen-2013 | Puzone, R.; Savarino, G.; Salvi, S.; Dal Bello, M. G.; Barletta, G.; Genova, C.; Rijavec, E.; Sini, C.; Esposito, A. I.; Ratto, G. B.; Truini, M.; Grossi, F.; Pfeffer, U. | |
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system | 1-gen-2014 | Truini, A.; Alama, A.; Dal-Bello, M. G.; Coco, S.; Vanni, I.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Grossi, F. | |
Looking for results in non-small-cell lung cancer: Is bio-chemotherapy the right answer? | 1-gen-2014 | Genova, C.; Rijavec, E.; Grossi, F. | |
Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer | 1-gen-2014 | Alama, A.; Truini, A.; Coco, S.; Genova, C.; Grossi, F. | |
Afatinib for the treatment of non-small cell lung cancer | 1-gen-2015 | Biello, F.; Maggioni, C.; Rijavec, E.; Genova, C.; Barletta, G.; Gualco, E.; Truini, A.; Coco, S.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Boccardo, F.; Grossi, F. | |
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer | 1-gen-2016 | Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F. | |
Hematopoietic growth factors in lung cancer | 1-gen-2016 | Genova, C.; Rijavec, E.; Grossi, F. | |
Vinflunine for the treatment of non-small cell lung cancer | 1-gen-2016 | Genova, C.; Alama, A.; Coco, S.; Rijavec, E.; Dal Bello, M. G.; Vanni, I.; Biello, F.; Barletta, G.; Rossi, G.; Grossi, F. | |
Recent advances in squamous non-small cell lung cancer: Evidence beyond predictive biomarkers | 1-gen-2016 | Genova, C.; Rijavec, E.; Grossi, F. | |
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy | 1-gen-2016 | Biello, Federica; Burrafato, Giovanni; Rijavec, Erika; Genova, Carlo; Barletta, Giulia; Truini, Anna; Coco, Simona; Bello, Maria Giovanna Dal; Alama, Angela; Boccardo, Francesco; Grossi, Francesco | |
Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: Can we use enemy territory at our advantage? | 1-gen-2017 | Genova, C.; Rijavec, E.; Grossi, F. | |
Understanding the checkpoint blockade in lung cancer immunotherapy | 1-gen-2017 | Dal Bello, M. G.; Alama, A.; Coco, S.; Vanni, I.; Grossi, F. | |
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study | 1-gen-2017 | Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco | |
Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy | 1-gen-2017 | Grossi, F.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Maggioni, C.; Burrafato, G.; Sini, C.; Dal Bello, M. G.; Meyer, K.; Roder, J.; Roder, H.; Grigorieva, J. | |
Exosomes: a new horizon in lung cancer | 1-gen-2017 | Vanni, I.; Alama, A.; Grossi, F.; Dal Bello, M. G.; Coco, S. | |
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy | 1-gen-2017 | Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile